Article

Differences in phakic lens design may explain HOA differences, researcher says

Technical differences in lens design may explain the variation in higher-order aberrations (HOAs) seen 1 year after implantation of a phakic IOL (Artisan, Ophtec) compared with a flexible version of the lens (Artiflex, Ophtec), reported Nayyirih G. Tahzib, MD, an ophthalmologist practicing at University Hospital Maastricht, Maastricht, Netherlands.

Technical differences in lens design may explain the variation in higher-order aberrations (HOAs) seen 1 year after implantation of a phakic IOL (Artisan, Ophtec) compared with a flexible version of the lens (Artiflex, Ophtec), reported Nayyirih G. Tahzib, MD, an ophthalmologist practicing at University Hospital Maastricht, Maastricht, Netherlands.

Dr. Tahzib and colleagues studied 27 eyes of 14 patients who underwent implantation of the flexible lens for the correction of myopia. Mean patient age was 41 ± 7.8 years (range, 26 to 51 years), and the mean spherical equivalent (SE) was –9.95 ± 1.43 D (range, –6.75 to –12.13 D).

The researchers recorded HOA values obtained via a wavefront aberrometer (Zywave, Bausch & Lomb) before surgery and 1 year postoperatively, and the values were correlated. They compared these HOA values with ones recorded for 22 eyes of 13 patients who received the non-flexible implantable contact lens for the correction of myopia. Members of that group had a mean age of 40 ± 12 years (range, 18 to 52 years) and a mean SE of –9.89 ± 2.74 D (–4 to –14.50 D).

The mean preoperative and postoperative spherical aberration (SA) values in the flexible implant group were 0.29 µm and 0.03 µm, respectively (p = 0.001). Mean preoperative and postoperative SA values in the non-flexible implant group were 0.19 µm and 0.60 µm, respectively (p = 0.001).

"This was a small study and, unfortunately, at this time, we don't have an explanation for the differences in SA patterns," Dr. Tahzib said. The variation may be related to differences in the designs of the lenses, including the incision sizes required for insertion and the optic materials, she added. "We hope to present new results next year."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.